Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8580765 Nucleoside phosphoramidate prodrugs

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 11, 2012
Date of Patent
November 12, 2013
Patent Application Number
13609614
Patent Citations Received
‌
US Patent 12121529 Nucleoside phosphoramidate prodrugs
0
‌
US Patent 11975016 2′-substituted-N
0
‌
US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
0
‌
US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
0
‌
US Patent 11690860 Treatment of HCV infected patients with cirrhosis
0
‌
US Patent 11707480 Highly active compounds against COVID-19
0
‌
US Patent 11707479 Combination formulation of two antiviral compounds
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8580765
Patent Primary Examiner
‌
Patrick Lewis

Find more entities like US Patent 8580765 Nucleoside phosphoramidate prodrugs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo